Li N. Komatsu

Array ( [id] => 11275903 [patent_doc_number] => 09492374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Composition and method for treatment of ulcers' [patent_app_type] => utility [patent_app_number] => 14/668930 [patent_app_country] => US [patent_app_date] => 2015-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3044 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14668930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11618336 [patent_doc_number] => 20170128524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'CELL-PERMEABLE PEPTIDE SYSTEM FOR TREATING DISEASES CAUSED BY GLUTAMATE EXCITOTOXICITY' [patent_app_type] => utility [patent_app_number] => 15/301760 [patent_app_country] => US [patent_app_date] => 2015-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10744 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15540847 [patent_doc_number] => 10570189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-25 [patent_title] => Muteins of clotting factor VIII [patent_app_type] => utility [patent_app_number] => 14/638760 [patent_app_country] => US [patent_app_date] => 2015-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23924 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14638760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10353559 [patent_doc_number] => 20150238563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'CYCLOSPORINE EMULSION' [patent_app_type] => utility [patent_app_number] => 14/638647 [patent_app_country] => US [patent_app_date] => 2015-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12966 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14638647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15225081 [patent_doc_number] => 10500245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Compositions for preventing and/or treating pathological conditions associated with alpha-glucosidase [patent_app_type] => utility [patent_app_number] => 15/119032 [patent_app_country] => US [patent_app_date] => 2015-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 21018 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15119032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11330877 [patent_doc_number] => 09522109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Skin collagen enhancing agent' [patent_app_type] => utility [patent_app_number] => 14/623243 [patent_app_country] => US [patent_app_date] => 2015-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4212 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14623243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11381620 [patent_doc_number] => 20170007675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'STABLE PEPTIDE FORMULATIONS AND METHODS FOR PREPARATION' [patent_app_type] => utility [patent_app_number] => 15/117016 [patent_app_country] => US [patent_app_date] => 2015-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19362 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15117016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10412661 [patent_doc_number] => 20150297670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => '\"Therapeutic Use of Peptide Inhibitors of NADPH Oxidase; Aerosolization as a Delivery Mechanism\"' [patent_app_type] => utility [patent_app_number] => 14/608655 [patent_app_country] => US [patent_app_date] => 2015-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8393 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14608655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10346199 [patent_doc_number] => 20150231205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL ISCHEMIA/REPERFUSION INJURY WITH ANNEXIN A1 SHORT PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/606872 [patent_app_country] => US [patent_app_date] => 2015-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8755 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14606872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10240616 [patent_doc_number] => 20150125611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'SELF-ASSEMBLING PEPTIDE AND PEPTIDE GEL WITH HIGH STRENGTH' [patent_app_type] => utility [patent_app_number] => 14/594503 [patent_app_country] => US [patent_app_date] => 2015-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10855 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14594503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11463847 [patent_doc_number] => 09580466 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-28 [patent_title] => 'Melanocortin-1 receptor-specific linear peptides' [patent_app_type] => utility [patent_app_number] => 14/585686 [patent_app_country] => US [patent_app_date] => 2014-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26409 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14585686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14119287 [patent_doc_number] => 10246490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-02 [patent_title] => Conotoxin peptide k-CPTX-BTL02, preparation method therefor, and uses thereof [patent_app_type] => utility [patent_app_number] => 15/539720 [patent_app_country] => US [patent_app_date] => 2014-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3552 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10346156 [patent_doc_number] => 20150231160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'RAPID-ACTING INSULIN FORMULATION COMPRISING AN OLIGOSACCHARIDE' [patent_app_type] => utility [patent_app_number] => 14/581239 [patent_app_country] => US [patent_app_date] => 2014-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 28114 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14581239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12367329 [patent_doc_number] => 09957311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-01 [patent_title] => Surface-binding peptide [patent_app_type] => utility [patent_app_number] => 15/106190 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12104 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10220326 [patent_doc_number] => 20150105319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'DURABLE HAEMOSTATIC SCAFFOLD' [patent_app_type] => utility [patent_app_number] => 14/577083 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3589 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14577083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11362885 [patent_doc_number] => 20170000866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'METHOD FOR EMULSIFYING A TRIEPITOPE PEPTIDE WITH MONTANIDE AND KITS FOR PERFORMING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/104858 [patent_app_country] => US [patent_app_date] => 2014-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4960 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12099201 [patent_doc_number] => 09856290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-02 [patent_title] => 'Glycopeptide compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 15/103452 [patent_app_country] => US [patent_app_date] => 2014-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 28469 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10311656 [patent_doc_number] => 20150196658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 14/553803 [patent_app_country] => US [patent_app_date] => 2014-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11455 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14553803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11641074 [patent_doc_number] => 09662422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation' [patent_app_type] => utility [patent_app_number] => 14/535033 [patent_app_country] => US [patent_app_date] => 2014-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 24727 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14535033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9917736 [patent_doc_number] => 20150072941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'DPY-30 Binding Peptides' [patent_app_type] => utility [patent_app_number] => 14/531570 [patent_app_country] => US [patent_app_date] => 2014-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24438 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14531570 [rel_patent_id] =>[rel_patent_doc_number] =>)